Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-06

Clinical Trial Update: Early Albumin Resuscitation During Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating early albumin resuscitation in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Septic Shock | Phase 4 | Status: COMPLETED